Target intelligence / Profile preview

microRNA 6805 (miR-6805)

Target
miR-6805
Molecular classification
Other (microRNA)
01

Overview

microRNA 6805 (miR-6805, specifically hsa-miR-6805-5p in humans) is a small non-coding RNA molecule that functions as a post-transcriptional regulator of gene expression, primarily by targeting messenger RNAs for degradation or translational inhibition. It has been studied as a biomarker for acute kidney injury, specifically cisplatin-induced nephrotoxicity, where downregulation of this miRNA in urine correlates with kidney damage after chemotherapy[1]. Predictive bioinformatics analyses suggest that miR-6805-5p may regulate pathways involved in the WNT signaling and cell adhesion, suggesting a possible role in renal cell regeneration and fibrotic processes, but it is not known as a direct target for drug intervention, nor is it considered a classical therapeutic target such as a receptor, enzyme, or transporter[1]. Its role is presently limited to biomarker applications rather than active drug targeting.

Other names
MIR6805hsa-mir-6805hsa-miR-6805-5pmicroRNA mir-6805
02

Mechanism of action

Not established as a direct drug target; regulates gene expression through sequence-specific silencing (canonical miRNA mechanism)

03

Biological functions

Post-transcriptional gene expression regulationSignal transduction (via WNT signaling)Cell adhesion molecule regulation
04

Disease associations

Kidney injury (biomarker for cisplatin-induced nephrotoxicity)Possibly cancer (not directly as a therapeutic target)
05

Safety considerations

Not a therapeutic target; no specific safety concerns reported for its use as a biomarker
06

Biomarkers

Urinary hsa-miR-6805-5p is a biomarker for cisplatin-induced nephrotoxicity (acute kidney injury)

Beyond the preview

Go deeper on microRNA 6805 (miR-6805).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 6805 (miR-6805).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call